These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20701081)

  • 1. Processing the entire serous effusion: advantages with the 3-dimensional filtration unit.
    Macchi RM; Patriarca C; Parente M; Arizzi C
    Anal Quant Cytol Histol; 2010 Apr; 32(2):116-9. PubMed ID: 20701081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparatory techniques of fluids and screening of malignant cells in effusions].
    Nagumo S
    Rinsho Byori; 1990 Nov; Suppl 87():191-200. PubMed ID: 2287088
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
    Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
    Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiments for increasing statement power of cytodiagnosis from cavitary effusions in malignant tumors. I. Modified methodical processing of cytological smears from effusions of the pleural cavity and ascites].
    Hoppe E; Wegewitz EM
    Radiobiol Radiother (Berl); 1975; 16(4):473-81. PubMed ID: 1208831
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemorrhagic cytology samples - how to get the best diagnostic results.
    Srebotnik Kirbis I; Strojan Flezar M; Lavrencak J; Pohar Marinsek Z
    Cytopathology; 2007 Jun; 18(3):175-9. PubMed ID: 17388935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic effects of prolonged storage on fresh effusion samples.
    Manosca F; Schinstine M; Fetsch PA; Sorbara L; Maria Wilder A; Brosky K; Erickson D; Raffeld M; Filie AC; Abati A
    Diagn Cytopathol; 2007 Jan; 35(1):6-11. PubMed ID: 17173298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods.
    Jing X; Li QK; Bedrossian U; Michael CW
    Am J Clin Pathol; 2013 Feb; 139(2):177-82. PubMed ID: 23355202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of serous effusion using three methods of investigation: conventional cytology, tetracycline test, and millipore filters].
    Pieron R; Kauffmann JP; Jagueux M
    Poumon Coeur; 1973 Feb; 29(2):111-2 passim. PubMed ID: 4777812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
    Marsan C; Gaulier A; Sabatier P; Garcia R
    Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic cytology of serous effusions (author's transl)].
    Djelali D
    Ther Umsch; 1973 Aug; 30(8):611-7. PubMed ID: 4751584
    [No Abstract]   [Full Text] [Related]  

  • 12. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmentation of color images from serous cytology for automated cell classification.
    Lezoray O; Elmoataz A; Cardot H; Gougeon G; Lecluse M; Elie H; Revenu M
    Anal Quant Cytol Histol; 2000 Aug; 22(4):311-22. PubMed ID: 10965407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of rare high-DNA cell populations in serous effusions using continuous-motion imaging.
    Tucker JH; Stark MH; Eason P; Duvall E
    Anal Cell Pathol; 1991 Jul; 3(4):233-42. PubMed ID: 1883747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytological variations observed in the malignant cells in body cavity fluids].
    Matsuda M
    Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosome analysis in effusions as a diagnostic adjunct to cytology.
    Augustus M; Visveshwara RN; Bhargava MK
    Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspirates.
    Elequin FT; Muggia FM; Ghossein NA; Schreiber K
    Acta Cytol; 1977; 21(4):596-9. PubMed ID: 269612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of cell cultures from pleural effusions and ascites].
    Sauter C
    Schweiz Med Wochenschr; 1971 Aug; 101(34):1245-7. PubMed ID: 5141783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytodiagnosis and cytomorphologic analysis of hematolymphoid malignancy in serous effusion: a study of 23 cases].
    He SR; Peng WX; Sun MJ; Yang L; He L; Su XL; He Q; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):691-5. PubMed ID: 23302312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.